-
Intranasal Psychedelics Platform Is Here, Check Out Mindset's New Development
Thursday, June 30, 2022 - 9:04am | 301Read More...In the process of creating optimized next-generation psychedelic medicines for neurological and psychiatric disorders, drug discovery and development company Mindset Pharma Inc. (OTCQB: MSSTF) has developed a novel, patent-pending, intranasal program formulation technology expected to deliver...
-
Frequency Therapeutics' FX-322 Data Published In Peer-Reviewed Journal
Tuesday, February 23, 2021 - 8:12am | 261Read More...Frequency Therapeutics Inc (NASDAQ: FREQ) has announced the publication of its lead candidate FX-322 Phase 1/2 study results in Otology & Neurotology. The data was initially announced in April 2019. The data showed hearing improvements in adults with acquired sensorineural...
